Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration

Figure 1

Adiponectin for age at diagnosis groups by (a) age and (b) diabetes duration at exam. Age at diagnosis groups 0–4, 5–9, 10–14, 15–19, and ≥20 years of age.

(a)

(b)